Cargando…
Cell therapy medicinal product regulatory framework in Europe and its application for MSC-based therapy development
Advanced therapy medicinal products (ATMPs), including cell therapy products, form a new class of medicines in the European Union. Since the ATMPs are at the forefront of scientific innovation in medicine, specific regulatory framework has been developed for these medicines and implemented from 2009...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Research Foundation
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3418507/ https://www.ncbi.nlm.nih.gov/pubmed/22912639 http://dx.doi.org/10.3389/fimmu.2012.00253 |